Algo version: 0.98b
Abbvie Inc is listed at the XETRA Exchange
Abbvie Inc [4AB.DE]
XETRA Sector: Biotechnology Industry:Drug Manufacturers—General

Is Abbvie Inc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Abbvie Inc pays dividends. Last time was Friday 15th of November 2024 where the investors holding the stock on Tuesday 15th of October 2024 were paid €1.39539 per share. Over the last 27 times between 2016 and 2024, Abbvie Inc has paid €32.25539 with an average of €1.19 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Abbvie Inc 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was €80.95, you would have made a profit of €93.65 per share or 115.69%

No, the average daily trading liquidity for Abbvie Inc is €641 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Abbvie Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.31, the company's ability to pay off the debt is normal. Abbvie Inc has a good net profit margin of 11.02% and should have high tolerances against inflation.

We have calculated the inflation risk for Abbvie Inc to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.